Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021;30(2):185-192.
doi: 10.1159/000513047. Epub 2020 Nov 16.

Assessment of Clinical Characteristics and Mortality-Associated Factors in COVID-19 Critical Cases in Kuwait

Affiliations

Assessment of Clinical Characteristics and Mortality-Associated Factors in COVID-19 Critical Cases in Kuwait

Mariam Ayed et al. Med Princ Pract. 2021.

Abstract

Objective: The objective of this study was to assess the clinical characteristics and identify mortality risk factors in intensive care unit (ICU)-admitted COVID-19 patients.

Methods: We recruited and analyzed SARS-CoV-2-infected adult patients (age ≥18 years) who were admitted to the ICU at Jaber Al-Ahmad Al Sabah Hospital, Kuwait, between March 1, 2020, and April 30, 2020. The risk factors associated with in-hospital mortality were assessed using multiple regression analysis.

Results: We recruited a total of 103 ICU patients in this retrospective cohort. The median age of the patients was 53 years and the fatality rate was 45.6%; majority (85.5%) were males and 37% patients had more than 2 comorbidities. Preexisting hypertension, moderate/severe acute respiratory distress syndrome, lymphocyte count <0.5 × 109, serum albumin <22 g/L, procalcitonin >0.2 ng/mL, D-dimer >1,200 ng/mL, and the need for continuous renal replacement therapy were significantly associated with mortality.

Conclusion: This study describes the clinical characteristics and risk factors for mortality among ICU patients with CO-VID-19. Early identification of risk factors for mortality might help improve outcomes.

Keywords: Acute respiratory distress syndrome; Coronavirus infection; Pneumonia; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors declare to have no conflicts of interests.

References

    1. Outbreak was declared a Public Health Emergency of International concern by WHO 2020. Jan 30. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-a.... - PMC - PubMed
    1. Kuwait confirms 3 coronavirus patients coming from Iran 2020. Feb 24. Available from: https://www.kuna.net.kw/ArticleDetails.aspx?id = 2864385&language = en.
    1. Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for coronavirus Disease 2019 (COVID-19): a review. JAMA. 2020;323((18)):1824–36. - PubMed
    1. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8((5)):475–81. - PMC - PubMed
    1. Zhong NS, Zheng BJ, Li YM, Poon LLM, Xie ZH, Chen KH, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet. 2003;362((9393)):1353–8. - PMC - PubMed